Precision Therapeutics Email Format
Biotechnology ResearchPennsylvania, United States51-200 Employees
Precision Therapeutics is a biotechnology research company focused on oncology. It maintains a cutting-edge research facility dedicated to oncology drug discovery and operates a CLIA-certified clinical laboratory. The broader description indicates that Helomics has been integrated into Predictive Oncology, which is headquartered in Pittsburgh. Recent developments in the Predictive Oncology ecosystem include launches of data resources intended to support AI infrastructure. The company has announced plans to bring its ChemoFx treatment-selection marker and tumor profiling assay to European markets. Overall, these activities illustrate a biotechnology research and diagnostic testing focus centered in Pittsburgh, with a blend of laboratory research and clinically oriented services.